• Revenue down 9.9% to $7.32M, loss of $866.6K
• Subscription revenue up 6% to $6.32M, 30 new clients signed
• Embracing AI to improve productivity and customer support
• R&D investment reduced by $590K to $2.1M

Global Health Limited reported a 9.9% decline in revenue to $7.32M and a loss of $866.6K for the financial year ended 30 June 2025. Despite the loss of $750K in revenue from SA Health, the company saw a 6% year-on-year increase in recurring subscriptions, boosted by a 16% increase in new SaaS revenue from existing and new clients. The company signed a total of 30 new-logo clients over FY2025, ranging from large, multiple location service providers to smaller service providers. To improve productivity and customer support, the company has embraced the use of artificial intelligence (AI). Large Language Models (LLM) have been built and maintained for individual products to support sales, marketing, deployment, support and development. The company has also implemented AI avatars as first-response for customer support, resulting in a 35% decrease in support ticket volumes and significant improvements in first response time and time to close tickets.The company's investment in research and development (R&D) was reduced by $590K to $2.1M, as the company focused on transitioning its PrimaryClinic and MasterCare EMR 'on-premise' applications to the multi-tenancy MasterCare Plus SaaS platform. The company expects the level of investment in R&D to revert to an industry standard ratio of 15% of expenses, with a focus on incorporating AI into its platforms to drive improved patient outcomes and service provider productivity.